Delivery Order SPE2DB20D2014-SPE2DB25FC96J
- Not listed
- The Defense Logistics Agency awarded a $1,202.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Polyethylene Glycol 3350 powder in 510-gram units. The contract is non-competitive and competitively awarded as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be completed by July 31, 2025, and will be fulfilled at...
- This federal contract award is for the delivery of 510 grams of polyethylene glycol 3350 powder, with a ceiling value of $3,398.16. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of July 11, 2025. The contract is not set aside for any...
- The U.S. government awarded a $5,513.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a performance period through February 2025, is for the supply of polyethylene glycol medical products to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, as well as a separate...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.93 to AmerisourceBergen Drug Corp for Plenvu Powder Packets 3S, a bowel preparation product used in medical procedures. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Plenvu Powder Packets in 3-pack quantities, with a contract ceiling value of $5,820.60. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,048.32 Delivery Order is for the supply of 4,000 milliliters of GOLYTELY Solution, a commonly prescribed gastrointestinal medication. The contract has a firm fixed price and an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a $1,952.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PLENVU Powder Packets 3S, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value through December 2026. The product—PLENVU powder packets—is a bowel preparation solution used for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,662.58 firm fixed-price delivery order is for the supply of MOVIPREP powder packets, with a performance period ending on May 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of MOVIPREP Powder Packets, a specialty medication, with a potential value of $3,937.08 and a completion date of January 30, 2024. The contract is a firm fixed price delivery order, and no set-aside designation was used. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.77 firm fixed-price delivery order is for the supply of 4567947880 COLACE 100 MG CAPSULE 60S, a medication used to treat constipation. The contract has an ultimate completion date of April 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC96JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,195.41 to AmerisourceBergen Drug Corp for Polyethylene Glycol 3350 Powder 30s, a pharmaceutical product commonly used for bowel preparation and constipation relief. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement channels. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025, just one day after the award date of September 10, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates consistent capability to supply a wide range of medications and medical supplies to support military healthcare programs worldwide across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/10/25 |